Effects of novel pyrrolomycin MP1 in MYCN amplified chemoresistant neuroblastoma cell lines alone and combined with temsirolimus.

BMC Cancer · 2019 · PMC6712804 · PMID 31455317

Europe PMC DOI

hedged sentence

0.0600

closest p · 1.2× alpha

0.0600

boldest claim

The sentences

approached significancep = 0.06so close (0.05 < p ≤ 0.1)

The combination group showed a decline in tumor growth rates compared to the other groups which approached significance ( p = 0.06) (Fig. 8 ) without weight loss (Additional file 5 : Figure S5).

also in 8,237 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.